Enrichment of lysophosphatidic acids with templated polymeric materials

US10773238B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10773238-B2
Application numberUS-201615553947-A
CountryUS
Kind codeB2
Filing dateFeb 23, 2016
Priority dateFeb 27, 2015
Publication dateSep 15, 2020
Grant dateSep 15, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of templated polymeric materials capable of binding lysophosphatidic acids (LPAs) are disclosed. Methods of making and using the templated polymeric materials also are disclosed. The disclosed templated polymeric materials are molecularly imprinted polymers that bind LPAs and facilitate the production of lysophosphatidic acid-enriched samples, for instance through extraction of lysophosphatidic acids from biological samples, such as plasma or serum samples.

First claim

Opening claim text (preview).

We claim: 1. A molecularly imprinted polymer, comprising: a plurality of first structural units derived from monomers comprising (a) at least one functional moiety selected from an amino, —N(H)C(O)N(H), —N(H)—C(S)—N(H)—, pyridyl, imidazolyl, pyrimidinyl, pyrazinyl, or cyclenyl moiety, or any combination thereof, and (b) at least one polymerizable moiety, the molecularly imprinted polymer having a molecular imprint having a size and shape complementary to a lysophosphatidic acid, wherein the molecularly imprinted polymer is obtained by: polymerizing the monomers in a solution comprising (i) a solvent, (ii) a guest molecule comprising an anionic head group comprising a phosphate or phosphonic acid group and a hydrophobic tail portion comprising a single hydrocarbon chain with a length of from 12-24 carbons, wherein the guest molecule is not a lysophosphatidic acid, (iii) a crosslinker, and (iv) a radical polymerization initiator to produce a polymer containing the guest molecule, and removing the guest molecule from the polymer containing the guest molecule to produce the molecularly imprinted polymer. 2. The molecularly imprinted polymer of claim 1 , wherein: (a) at least some of the monomers comprise a plurality of functional moieties capable of binding to a phosphate group; or (b) the polymerizable moiety comprises a terminal ethenyl group; or (c) both (a) and (b). 3. The molecularly imprinted polymer of claim 1 , wherein the first structural units are derived from monomers according to one of the following five chemical structures or a combination of two or more thereof: 4. The molecularly imprinted polymer of claim 1 , further comprising a plurality of second structural units derived from 2 vinylpyridine, 4-vinylpyridine, 1-vinylimidazole, 4-vinylimidazole, 1-allylthiourea, methacrylic acid, or a combination of two or more thereof. 5. The molecularly imprinted polymer of claim 4 , wherein the first structural unit and the second structural unit are present in a mole ratio from 10:1 to 1:10. 6. The molecularly imprinted polymer of claim 1 , wherein: (a) the crosslinker comprises ethylene glycol dimethacrylate (EGDMA), divinylbenzene (DVB), tetraethylene glycol dimethacrylate (TEGDMA), N,O-bismethacrylolyl ethanolamine (NOBE), N,N′-methylenebismethacrylamide (MMAA), triallyl isocyanurate (TAIL), trimethylolpropane trimethacrylate (TRIM), or a combination of two or more thereof; or (b) the radical polymerization initiator comprises 2,2′-azobisisobutyronitrile; or (c) both (a) and (b). 7. The molecularly imprinted polymer of claim 3 , wherein: (a) the polymer comprises first structural units derived from monomer 1 and the crosslinker in a mole ratio of 1:5 to 1:50; or (b) the molecularly imprinted polymer comprises first structural units derived from monomer 1, second structural units derived from methacrylic acid, and EGDMA in a 1:1:20 mole ratio. 8. The molecularly imprinted polymer of claim 1 , wherein the first structural units are derived from monomer 1, monomer 2, or a combination thereof: 9. A molecularly imprinted polymer, comprising: a plurality of first structural units derived from monomers comprising (a) at least one functional moiety selected from an amino, —N(H)C(O)N(H), —N(H)—C(S)—N(H)—, pyridyl, imidazolyl, pyrimidinyl, pyrazinyl, or cyclenyl moiety, or any combination thereof, and (b) at least one polymerizable moiety, the molecularly imprinted polymer having a molecular imprint having a size and shape complementary to a lysophosphatidic acid, wherein the molecularly imprinted polymer is obtained by: polymerizing the monomers in a solution comprising (i) a solvent, (ii) a guest molecule, wherein the guest molecule is octadecylphosphonic acid, (iii) a crosslinker, and (iv) a radical polymerization initiator to produce a polymer containing the guest molecule, and removing the guest molecule from the polymer containing the guest molecule to produce the molecularly imprinted polymer. 10. A method for producing a molecularly imprinted polymer for binding a lysophosphatidic acid, the method comprising: polymerizing monomers comprising (a) at least one functional moiety selected from an amino, —N(H)—C(O)—N(H)—, —N(H)—C(S)—N(H)—, pyridyl, imidazolyl, pyrimidinyl, pyrazinyl, or cyclenyl moiety, or any combination thereof, and (b) at least one polymerizable moiety in a solution comprising (i) a solvent, (ii) a guest molecule comprising an anionic head group comprising a phosphate or phosphonic acid group and a hydrophobic tail portion comprising a single hydrocarbon chain with a length of from 12-24 carbons, wherein the guest molecule is not a lysophosphatidic acid, (iii) a crosslinker, and (iv) a radical polymerization initiator to produce a polymer containing the anionic guest molecule; and removing the guest molecule from the polymer containing the guest molecule to produce a molecularly imprinted polymer having a molecular imprint having a size and shape complementary to lysophosphatidic acid. 11. The method of claim 10 , wherein the monomers are monomers according to one of the following five chemical structures or a combination of two or more thereof: 12. The method of claim 10 , wherein the monomers further comprise 2-vinylpyridine, 4-vinylpyridine, 1-vinylimidazole, 4-vinylimidazole, 1-allylthiourea, methacrylic acid, or a combination of two or more thereof. 13. A method of preparing a lysophosphatidic acid-enriched sample, comprising: loading a solution comprising one or more lysophosphatidic acid species onto a solid-phase extraction cartridge including a stationary phase comprising a molecularly-imprinted polymer according to claim 1 (MIP SPE cartridge); flowing chloroform and subsequently a lower alkyl alcohol through the MIP SPE cartridge; and flowing an alkaline solution comprising a lower alkyl alcohol through the MIP SPE cartridge, thereby eluting at least a portion of the lysophosphatidic acid species from the MIP SPE cartridge to provide a lysophosphatidic acid-enriched sample. 14. The method of claim 13 , further comprising preparing the solution comprising one or more lysophosphatidic acid species by: combining a sample comprising plasma or serum with a solvent comprising a lower alkyl alcohol and chloroform to form a mixture; separating the mixture to provide a supernatant and a precipitate; acidifying the supernatant to provide the solution comprising one or more lysophosphatidic acid species. 15. The method of claim 14 , wherein acidifying the supernatant further comprises: after separating the mixture, loading the supernatant onto a SPE cartridge including a stationary phase comprising a non-imprinted polymer comprising (i) a plurality of first structural units derived from monomers comprising (a) at least one functional moiety capable of binding to a phosphate group and (b) at least one polymerizable moiety (NIP SPE cartridge), and (ii) a crosslinker; flowing an alkaline solution comprising a lower alkyl alcohol through the NIP SPE cartridge to provide an eluent; and acidifying the eluent to provide the solution comprising one or more lysophosphatidic acid species. 16. The method of claim 15 , wherein the first structural units of the non-imprinted polymer are derived from monomers according to one of the following five chemical s

Assignees

Inventors

Classifications

  • Use of a templating or imprinting material (molecularly imprinted polymers B01J20/268); filling pores of a substrate or matrix followed by the removal of the substrate or matrix · CPC title

  • extracting sample from raw material · CPC title

  • Extraction · CPC title

  • involving viable microorganisms · CPC title

  • based on polymers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10773238B2 cover?
Embodiments of templated polymeric materials capable of binding lysophosphatidic acids (LPAs) are disclosed. Methods of making and using the templated polymeric materials also are disclosed. The disclosed templated polymeric materials are molecularly imprinted polymers that bind LPAs and facilitate the production of lysophosphatidic acid-enriched samples, for instance through extraction of lyso…
Who is the assignee on this patent?
Univ Portland State
What technology area does this patent fall under?
Primary CPC classification B01J20/268. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).